跳至主要内容
临床试验/NCT03098641
NCT03098641已完成不适用

Transvaginal Treatment of Anterior and Apical Genital Prolapses Using an Ultra Lightweight Mesh: Restorelle® Direct FixTM: a Retrospective Study on Feasibility and Morbidity.

Groupe Hospitalier de la Rochelle Ré Aunis16 个研究点 分布在 1 个国家目标入组 272 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
272
试验地点
16
主要终点
Number of Patients With a Composite Outcome : Bladder Wound, Rectum Wound, Abnormal Bleeding

研究概览

简要总结

Pelvic organ prolapse repair involves conservative treatments and surgical treatments. Conservative treatments are for patients with moderate prolapse. Treatment of symptomatic prolapse remains essentially surgical. According to detailed medical history and a thorough physical exam, surgical techniques may be performed by high abdominal, low vaginal or mixed routes with or without the use of a reinforcing implant. Restorelle Direct Fix is indicated for transvaginal anterior and posterior surgical repair either as mechanical support or as reinforcement of pelvic floor defects. Advantages and disadvantages of vaginal prostheses are known but only limited data have been reported on the use of Restorelle® in the treatment of pelvic organ prolapse. This study is designed to collect data on the safety and efficacy of Restorelle® Direct Fix in pelvic organ prolapse repair.

详细描述

Between January 2013 and December 2016, in the participating centers, all adult women who underwent surgery to repair pelvic organ prolapse (recurrent or not) through the vagina with the addition of anterior and/or posterior Restorelle Direct Fix prosthesis are eligible. Collected data are about the peri-operative period and the data available at the last consultation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • woman who underwent surgery to repair pelvic organ prolapse (recurrent or not) through the vagina with the addition of anterior and/or posterior Restorelle Direct Fix prosthesis
  • informed and not opposed to the use of her data

排除标准

  • Opposed to the use of her data

结局指标

主要结局

Number of Patients With a Composite Outcome : Bladder Wound, Rectum Wound, Abnormal Bleeding

时间窗: up to 30 days after surgery

Perioperative morbidity

次要结局

  • Number of Patients With Postoperative Urinary Signs(up to 4 years after surgery)
  • Number of Patients With Late Complications(up to 4 years after surgery)
  • Number of Patients With Postoperative Active Sexuality(up to 4 years after surgery)
  • Postoperative Score at Numeric Pain Rating Scale(up to 48 hours after surgery)
  • Number of Patients With Early Complications(up to 30 days after surgery)
  • Pelvic Organ Prolapse Quantification (POP-Q) Exam Before Surgery(preoperative, within 48 hours before surgery)
  • Pelvic Organ Prolapse Quantification (POP-Q) Exam After Surgery(up to 4 years after surgery)
  • Number of Patients With Preoperative Urinary Signs(within 4 weeks before surgery)
  • Number of Patients With Preoperative Digestive Signs(within 4 weeks before surgery)
  • Number of Patients With Postoperative Digestive Signs(up to 4 years after surgery)
  • Number of Patients With Preoperative Active Sexuality(within 4 weeks before surgery)
  • Number of Patients With Preoperative Dyspareunia(within 4 weeks before surgery)
  • Number of Patients With Postoperative Dyspareunia(up to 4 years after surgery)
  • Preoperative Score at Numeric Pain Rating Scale(Within 48 hours before surgery)

研究者

发起方
Groupe Hospitalier de la Rochelle Ré Aunis
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

Smartmesh Technology in Pelvic Floor Repair... | 临床试验